Vital Signs - Pharmacogenomics and Drugs: Now its Personal!
Vital Signs - Pharmacogenomics and Drugs: Now its Personal!
RELEASE DATE
23-Nov-2009
23-Nov-2009
REGION
North America
North America
Research Code: 9561-00-9C-00-00
SKU: HC00585-NA-MR_04058
$1,500.00
Special Price $1,125.00 save 25 %
In stock
SKU
HC00585-NA-MR_04058
Description
This issue of Vital Signs, released on November 23, 2009, provides a strategic overview of trends in pharmacogenomic testing and drug development. Additionally, a company spotlight is provided for Paratek Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of innovative new therapies that treat and prevent infectious diseases and other disorders. Reimbursement and regulatory news from the FDA is also provided for the week of November 9, 2009.
Table of Contents
This week's issue:
Popular Topics
This issue of Vital Signs, released on November 23, 2009, provides a strategic overview of trends in pharmacogenomic testing and drug development. Additionally, a company spotlight is provided for Paratek Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of innovative new therapies that treat and prevent infectious diseases and other disorders. Reimbursement and regulatory news from the FDA is also provided for the week of November 9, 2009.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-9C-00-00 |
Is Prebook | No |